SELECTIVE NEURODEGENERATION, NEUROPATHOLOGY AND SYMPTOM PROFILES IN HUNTINGTON'S DISEASE

被引:0
|
作者
Waldvogel, Henry J. [1 ,2 ]
Thu, Doris [3 ]
Hogg, Virginia [2 ,4 ]
Tippett, Lynette [2 ,4 ]
Faull, Richard L. M. [1 ,2 ]
机构
[1] Univ Auckland, Dept Anat Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand
[2] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand
[3] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland
[4] Univ Auckland, Dept Psychol, Auckland, New Zealand
来源
TANDEM REPEAT POLYMORPHISMS: GENETIC PLASTICITY, NEURAL DIVERSITY AND DISEASE | 2012年 / 769卷
关键词
CELL-CELL INTERACTIONS; CAG REPEAT LENGTH; BASAL GANGLIA; MOUSE MODEL; NEUROTROPHIC FACTOR; PROJECTION NEURONS; CLINICAL-FEATURES; DIFFERENTIAL LOSS; STRIATAL NEURONS; CEREBRAL-CORTEX;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Huntington's disease (HD) is an autosomal dominant inherited neurodegenerative disease caused by a CAG repeat expansion in exon 1 of the Huntington gene (HD) also known as IT15. Despite the disease being caused by dysfunction of a single gene, expressed as an expanded polyglutamine in the huntingtin protein, there is a major variability in the symptom profile of patients with Huntington's disease as well as great variability in the neuropathology. The symptoms vary throughout the course of the disease and vary greatly between cases. These symptoms present as varying degrees of involuntary movements, mood, personality changes, cognitive changes and dementia. To determine whether there is a morphological basis for this symptom variability, recent studies have investigated the cellular and neurochemical changes in the striatum and cerebral cortex in the human brain to determine whether there is a link between the pathology in these regions and the symptomatology shown by individual cases. These studies together revealed that cases showing mainly mood symptom profiles correlated with marked degeneration in the strio-somal compartment of the striatum, or in the anterior cingulate gyrus of the cerebral cortex. In contrast, in cases with mainly motor symptoms neurodegeneration was especially marked in the primary motor cortex with variable degeneration in both the striosomes and matrix compartments of the striatum. These studies suggest that the variable degeneration of the striatum and cerebral cortex correlates with the variable profiles of Huntington's disease.
引用
收藏
页码:141 / 152
页数:12
相关论文
共 50 条
  • [21] Neurodegeneration - A fly's eye view of Huntington's disease
    Mitchell, A
    NATURE, 1998, 395 (6705) : 841 - 841
  • [23] Widespread Brainstem Neurodegeneration in Huntington's Disease (HD)
    Rueb, Udo
    Vonsattel, Jean Paul G.
    Heinsen, Helmut
    Korf, Horst-Werner
    NEUROPATHOLOGY OF HUNTINGTON'S DISEASE: CLASSICAL FINDINGS, RECENT DEVELOPMENTS AND CORRELATION TO FUNCTIONAL NEUROANATOMY, 2015, 217 : 83 - 90
  • [24] Glycation potentiates neurodegeneration in models of Huntington’s disease
    Hugo Vicente Miranda
    Marcos António Gomes
    Joana Branco-Santos
    Carlo Breda
    Diana F. Lázaro
    Luísa Vaqueiro Lopes
    Federico Herrera
    Flaviano Giorgini
    Tiago Fleming Outeiro
    Scientific Reports, 6
  • [25] Dopaminergic signaling and striatal neurodegeneration in Huntington's disease
    Tang, Tie-Shan
    Chen, Xi
    Liu, Jing
    Bezprozvanny, Ilya
    JOURNAL OF NEUROSCIENCE, 2007, 27 (30): : 7899 - 7910
  • [26] Glycation potentiates neurodegeneration in models of Huntington's disease
    Vicente Miranda, Hugo
    Gomes, Marcos Antonio
    Branco-Santos, Joana
    Breda, Carlo
    Lazaro, Diana F.
    Lopes, Lusa Vaqueiro
    Herrera, Federico
    Giorgini, Flaviano
    Outeiro, Tiago Fleming
    SCIENTIFIC REPORTS, 2016, 6
  • [27] GLYCATION POTENTIATES NEURODEGENERATION IN MODELS OF HUNTINGTON'S DISEASE
    Outeiro, Tiago Fleming
    Miranda, Hugo V.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A11 - A11
  • [28] The Paradigm of Huntington's Disease: Therapeutic Opportunities in Neurodegeneration
    Leegwater-Kim J.
    Cha J.-H.J.
    NeuroRX, 2004, 1 (1): : 128 - 138
  • [29] Getting a handle on Huntington's disease: silencing neurodegeneration
    Albert R La Spada
    Nature Medicine, 2009, 15 (3) : 252 - 253
  • [30] Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
    Gutekunst, CA
    Li, SH
    Yi, H
    Mulroy, JS
    Kuemmerle, S
    Jones, R
    Rye, D
    Ferrante, RJ
    Hersch, SM
    Li, XJ
    JOURNAL OF NEUROSCIENCE, 1999, 19 (07): : 2522 - 2534